A groundbreaking French study has revealed the hidden dangers that pregnant women with systemic sclerosis (SSc) face, highlighting an increased risk of pregnancy complications and a higher likelihood of disease progression after childbirth compared to the general population. This research, conducted as part of the GR2 French prospective registry, followed 58 pregnancies in 52 women diagnosed with SSc or Very Early Diagnosis of Systemic Sclerosis (VEDOSS) between 2014 and 2020.
The study's findings are a wake-up call, emphasizing the critical need for specialized care and monitoring for this high-risk group. With a live birth rate of 91.4%, the study also uncovered a concerning 26.4% rate of composite adverse outcomes, including preterm births at 34 weeks or earlier, placental insufficiency, small-for-gestational-age infants, and fetal and neonatal deaths.
But here's where it gets controversial: the rate of placental complications, such as preeclampsia and fetal growth restriction, reached a staggering 22.6%, and severe postpartum hemorrhage occurred in 11.3% of cases, significantly higher than the 1.4% seen in the general French perinatal survey.
When compared to over 500 age-matched controls from France's 2016 national perinatal survey, the study found that pregnancies in women with SSc had higher rates of preeclampsia (13.2% vs. 3.0%), preterm birth before 37 weeks (13.2% vs. 5.8%), low birth weight under 2,500 g (21.1% vs. 4.3%), and severe postpartum hemorrhage (11.3% vs. 1.4%).
These statistics emphasize the importance of specialized obstetric and rheumatology care before, during, and after pregnancy for women with SSc or VEDOSS.
And this is the part most people miss: beyond the immediate obstetric complications, the study found that systemic sclerosis worsened in nearly 40% of pregnancies, mainly after delivery. Women with diffuse cutaneous SSc or a history of cutaneous vascular involvement were at an even higher risk of postpartum disease flare-ups.
"Our results highlight the need for close, multidisciplinary follow-up, especially in the postpartum period," said lead author Anne Murarasu of Paris Descartes University. "While successful pregnancies are possible for most women with systemic sclerosis, the risk of maternal and fetal complications remains significantly elevated."
The study's findings underscore the importance of individualized preconception counseling and tailored pregnancy monitoring. Early identification of high-risk features, such as diffuse cutaneous involvement, is crucial for guiding closer surveillance and proactive management to ensure the best possible outcomes for both the mother and child.
So, what do you think? Are these findings a call to action for better care and support for pregnant women with systemic sclerosis? Or do you think there's more to the story? Let's discuss in the comments and share our thoughts on this important topic!
